Atara Biotherapeutics, Inc.

NASDAQ:ATRA

11.4 (USD) • At close December 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q1
Revenue 40.1928.6427.3574.2522.1380.9571.2260.2214.45951.5797.3147.5485.373.873.552358.1920000000000000000000000000000000
Cost of Revenue 7.6024.6271.9853.162.6152.8950.2164.0674.14164.8982.2253.18470.33368.4752.595179.09659.87761.5657.6590000000000000000000000000000
Gross Profit 32.58824.01325.3721.092-0.477-1.9381.01-3.8460.318-13.3195.0894.364-64.963-64.6050.957179.096-59.877-61.56-57.6590000000000000000000000000000
Gross Profit Ratio 0.8110.8380.9270.257-0.223-2.0250.824-17.4030.071-0.2580.6960.578-12.097-16.6940.2690.50000000000000000000000000000000
Reseach & Development Expenses 43.92433.33242.11243.98156.88856.14162.15662.51570.15764.89874.96379.13470.33368.47564.05965.55459.87761.5657.65961.6453.53852.25148.66862.25543.35533.38728.4624.77120.59818.29617.54113.47418.80212.99111.24720.7318.1137.0075.7675.0484.2413.1762.9812.2521.6840.5690.354
General & Administrative Expenses 10.4218.91211.11311.45412.24713.33513.87213.24518.92418.81320.57121.81719.84919.39717.73816.14314.82916.39217.03818.05919.01823.28419.22319.56116.86519.23613.99211.03111.0629.6138.625.287.146.4945.8145.5394.1463.6013.5445.5481.7081.3584.0961.1650.8680.7920.932
Selling & Marketing Expenses 00-1.357-1.0660000000000000000000000000000000000000000000
SG&A 10.4218.9129.75610.38812.24713.33513.87213.24518.92418.81320.57121.81719.84919.39717.73816.14314.82916.39217.03818.05919.01823.28419.22319.56116.86519.23613.99211.03111.0629.6138.625.287.146.4945.8145.5394.1463.6013.5445.5481.7081.3584.0961.1650.8680.7920.932
Other Expenses 000.068-0.012-0.027-0.01-0.1970000000000000000000000000000004.501.0660000000
Operating Expenses 54.34542.24451.86854.36969.13569.47676.02875.7689.08183.71195.534100.95190.18287.87281.79781.69774.70677.95274.69779.69972.55675.53567.89181.81660.2252.62342.45235.80231.6627.90926.16118.75425.94219.48517.06126.2712.25910.6089.31110.5965.9494.5347.0773.4172.5521.3611.286
Operating Income -21.757-18.231-26.496-53.277-69.612-71.414-75.018-75.539-84.622-32.132-88.22-95.891-84.812-84.002-78.245-81.697-74.706-77.952-74.697-79.699-72.556-75.535-67.891-81.816-60.22-52.623-42.452-35.802-31.66-27.909-26.161-18.754-25.942-19.485-17.061-21.77-12.259-15.108-9.311-10.596-5.949-4.534-7.077-3.417-2.552-1.361-1.286
Operating Income Ratio -0.541-0.637-0.969-12.53-32.559-74.623-61.189-341.805-18.978-0.623-12.062-12.704-15.794-21.706-22.028-0.2280000000000000000000000000000000
Total Other Income Expenses Net -0.169-0.818-0.481-0.477-0.2040.3070.2690.9690.54150.5980.1150.0840.1480.225-0.090.3980.3640.4971.1881.2150.6611.2071.6341.7571.8591.7431.0090.4730.5640.4810.5090.5190.5760.6050.5030.5220.380.1630.1530.0660.030.0230.0060.0040.0030.0040.002
Income Before Tax -21.926-19.049-31.728-60.439-69.816-71.107-74.749-74.57-84.08118.466-88.105-93.319-84.664-83.777-78.335-81.299-74.342-77.455-73.509-78.484-71.895-74.328-66.257-80.059-58.361-50.88-41.443-35.329-31.096-27.428-25.652-18.235-25.366-18.88-16.558-21.248-11.879-14.945-9.158-10.53-5.919-4.511-7.071-3.413-2.549-1.357-1.284
Income Before Tax Ratio -0.546-0.665-1.16-14.214-32.655-74.302-60.97-337.421-18.8560.358-12.046-12.363-15.766-21.648-22.054-0.2270000000000000000000000000000000
Income Tax Expense -0.01700.0240.011-0.0190.0010.0220.0020.01-50.598-0.1150.03-0.5410.016-0.3730.0080.0060.00100.012000-0.04700.0030-0.016000.002-0.1730.00700.003-0.027-0.0114.3320.002-0.00300.003-0.0220.143-0.0130.0260.014
Net Income -21.909-19.049-317.52-604.5-697.97-711.08-747.71-745.72-840.91184.66-881.05-933.49-846.64-837.93-783.35-813.07-743.48-774.56-735.09-784.96-718.95-743.28-662.57-800.12-583.61-508.83-414.43-353.13-310.96-274.28-256.54-182.35-253.73-188.8-165.61-212.48-118.68-149.45-91.6-105.27-59.19-45.11-70.49-35.56-25.36-13.83-12.98
Net Income Ratio -0.545-0.665-11.607-142.168-326.459-743.03-609.878-3,374.299-188.5870.358-12.046-12.367-15.766-21.652-22.054-0.2270000000000000000000000000000000
EPS -2.93-3.1-5.65-13.98-16.4-16.91-17.98-18.07-20.534.54-21.87-23.96-22.61-22.73-21.41-23.83-22.9-28.49-30.02-34.03-32.73-40.02-35.91-43.7-32.13-28.66-26.17-28.8-25.51-23.45-22.07-15.77-22.02-16.47-14.51-18.7-10.72-15.42-10.45-16.65-104.91-84.35-139.49-78.62-69.61-37.44-1.56
EPS Diluted -2.93-3.1-5.65-13.98-16.4-16.91-17.98-18.07-20.534.5-21.87-23.96-22.61-22.75-21.41-23.83-22.9-28.49-30.02-34.03-32.73-40.02-35.91-43.7-32.13-28.66-26.17-28.8-25.51-23.45-22.07-15.77-22.02-16.47-14.51-18.7-10.72-15.42-10.45-16.65-104.91-84.35-139.49-78.62-69.61-37.44-1.56
EBITDA -19.513-16.457-29.184-58.058-67.185-68.528-69.32-74.284-82.589-30.694-86.51-90.915-82.495-81.684-76.023-79.54-72.533-75.899-72.748-77.803-70.767-73.798-66.243-82.313-59.03-51.876-42.119-35.524-31.41-27.687-25.955-18.581-25.811-19.421-17.046-26.243-12.249-15.103-9.305-10.594-5.947-4.534-7.076-3.416-2.551-1.36-1.285
EBITDA Ratio -0.486-0.575-0.918-12.246-31.437-71.607-61.189-341.805-18.671-1.569-11.844-12.375-15.362-21.107-21.403-0.2280000000000000000000000000000000